These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29644616)

  • 1. Genetic aberrations of the K-ras proto-oncogene in bladder cancer in relation to pesticide exposure.
    Hameed DA; Yassa HA; Agban MN; Hanna RT; Elderwy AM; Zwaita MA
    Environ Sci Pollut Res Int; 2018 Aug; 25(22):21535-21542. PubMed ID: 29644616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts.
    Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Fujii H; Pelling JC; Cohen SM
    Cancer Res; 1991 Jul; 51(13):3471-5. PubMed ID: 2054786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple method to reveal possible ras mutations in DNA of urinary sediment cells.
    Cristaudo A; Vivaldi A; Guglielmi G; Sensales G; Ottenga F
    J Environ Pathol Toxicol Oncol; 1997; 16(2-3):201-4. PubMed ID: 9276002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a GIS-based indicator for environmental pesticide exposure and its application to a Belgian case-control study on bladder cancer.
    Cornelis C; Schoeters G; Kellen E; Buntinx F; Zeegers M
    Int J Hyg Environ Health; 2009 Mar; 212(2):172-85. PubMed ID: 18768353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
    Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C
    J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic aberrations of the K-ras proto-oncogene in bladder cancer in Kashmiri population.
    Nanda MS; Sameer AS; Syeed N; Shah ZA; Murtaza I; Siddiqi MA; Ali A
    Urol J; 2010; 7(3):168-73. PubMed ID: 20845292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection and clinical pathological significance of the expression of P21, P185, p53 proteins and mutation of ras, p53 genes in transitional cell carcinoma of the bladder].
    Yu D; Liu F; Liang Z
    Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):202-5. PubMed ID: 9275651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K-RAS mutation in transitional cell carcinoma of urinary bladder.
    Ayan S; Gokce G; Kilicarslan H; Ozdemir O; Yildiz E; Gultekin EY
    Int Urol Nephrol; 2001; 33(2):363-7. PubMed ID: 12092657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
    Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study.
    Slebos RJ; Hoppin JA; Tolbert PE; Holly EA; Brock JW; Zhang RH; Bracci PM; Foley J; Stockton P; McGregor LM; Flake GP; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1223-32. PubMed ID: 11097231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organochlorine Pesticides Exposure and Bladder Cancer: Evaluation from a Gene-Environment Perspective in a Hospital-Based Case-Control Study in the Canary Islands (Spain).
    Boada LD; Henríquez-Hernández LA; Zumbado M; Almeida-González M; Álvarez-León EE; Navarro P; Luzardo OP
    J Agromedicine; 2016; 21(1):34-42. PubMed ID: 26479327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low incidence of mutations in codon 12 of the c-K-ras gene in bladder cancer].
    Ejarque MJ; Villanueva A; Chechile G; Regalado R; Errando C; Algaba F; Capella G; Lluis F; Villavicencio H; Vicente J
    Actas Urol Esp; 1995 Sep; 19(8):599-603. PubMed ID: 8669326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pesticides, gene polymorphisms, and bladder cancer among Egyptian agricultural workers.
    Amr S; Dawson R; Saleh DA; Magder LS; St George DM; El-Daly M; Squibb K; Mikhail NN; Abdel-Hamid M; Khaled H; Loffredo CA
    Arch Environ Occup Health; 2015; 70(1):19-26. PubMed ID: 24219772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction to: Genetic aberrations of the K-ras proto-oncogene in bladder cancer in relation to pesticide exposure.
    Hameed DA; Yassa HA; Agban MN; Hanna RT; Elderwy AM; Zwaita MA
    Environ Sci Pollut Res Int; 2018 Aug; 25(22):21543. PubMed ID: 29971738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis.
    Nelson HH; Christiani DC; Wiencke JK; Mark EJ; Wain JC; Kelsey KT
    Cancer Res; 1999 Sep; 59(18):4570-3. PubMed ID: 10493509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer.
    Alguacil J; Porta M; Kauppinen T; Malats N; Kogevinas M; Carrato A;
    Int J Cancer; 2003 Nov; 107(4):635-41. PubMed ID: 14520703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer and past occupational exposure to asbestos. Role of p53 and K-ras mutations.
    Husgafvel-Pursiainen K; Karjalainen A; Kannio A; Anttila S; Partanen T; Ojajärvi A; Vainio H
    Am J Respir Cell Mol Biol; 1999 Apr; 20(4):667-74. PubMed ID: 10100998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated H-ras gene mutations in transitional cell carcinoma of urinary bladder in a Kashmiri population.
    Pandith AA; Shah Z; Rasool R; Dil-Afroze ; Yousuf A; Parveen N; Wani S; Siddiqi M
    Tumori; 2010; 96(6):993-8. PubMed ID: 21388064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.
    Calistri D; Rengucci C; Seymour I; Lattuneddu A; Polifemo AM; Monti F; Saragoni L; Amadori D
    J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.